NYSE:GMED Globus Medical (GMED) Stock Price, News & Analysis → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free GMED Stock Alerts $50.37 -1.07 (-2.08%) (As of 05:32 PM ET) Add Compare Share Share Today's Range$50.02▼$51.4050-Day Range$50.37▼$56.4352-Week Range$43.38▼$62.88Volume613,281 shsAverage Volume1.12 million shsMarket Capitalization$6.82 billionP/E Ratio43.05Dividend YieldN/APrice Target$66.33 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Globus Medical alerts: Email Address Globus Medical MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside30.9% Upside$66.33 Price TargetShort InterestBearish5.55% of Shares Sold ShortDividend StrengthN/ASustainability-0.93Upright™ Environmental ScoreNews Sentiment0.91Based on 2 Articles This WeekInsider TradingSelling Shares$550,574 Sold Last QuarterProj. Earnings Growth21.93%From $2.69 to $3.28 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.86 out of 5 starsMedical Sector51st out of 907 stocksSurgical & Medical Instruments Industry9th out of 96 stocks 3.3 Analyst's Opinion Consensus RatingGlobus Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageGlobus Medical has only been the subject of 3 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted5.55% of the outstanding shares of Globus Medical have been sold short.Short Interest Ratio / Days to CoverGlobus Medical has a short interest ratio ("days to cover") of 7.2.Change versus previous monthShort interest in Globus Medical has recently decreased by 3.22%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldGlobus Medical does not currently pay a dividend.Dividend GrowthGlobus Medical does not have a long track record of dividend growth. Previous Next 4.1 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreGlobus Medical has received a 57.33% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Neurostimulators", "Synthetic bone grafts", "Artificial joints", and "Robotic surgery systems" products. See details.Environmental SustainabilityThe Environmental Impact score for Globus Medical is -0.93. Previous Next 2.7 News and Social Media Coverage News SentimentGlobus Medical has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.42 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Globus Medical this week, compared to 4 articles on an average week.Search InterestOnly 2 people have searched for GMED on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows4 people have added Globus Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Globus Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $550,574.00 in company stock.Percentage Held by Insiders24.30% of the stock of Globus Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions95.16% of the stock of Globus Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Globus Medical are expected to grow by 21.93% in the coming year, from $2.69 to $3.28 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Globus Medical is 43.30, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 140.57.Price to Earnings Ratio vs. SectorThe P/E ratio of Globus Medical is 43.30, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 203.97.Price to Earnings Growth RatioGlobus Medical has a PEG Ratio of 1.51. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioGlobus Medical has a P/B Ratio of 1.73. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. About Globus Medical Stock (NYSE:GMED)Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.Read More GMED Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GMED Stock News HeadlinesApril 25, 2024 | finance.yahoo.comWhat Is Globus Medical, Inc.'s (NYSE:GMED) Share Price Doing?April 18, 2024 | msn.comGlobus Medical to Unveil First Quarter Financial Results, Host Conference CallApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.April 16, 2024 | finance.yahoo.comGlobus Medical Schedules First Quarter Earnings Release and Conference CallApril 15, 2024 | americanbankingnews.comShort Interest in Globus Medical, Inc. (NYSE:GMED) Rises By 32.4%April 15, 2024 | americanbankingnews.comAnalyzing Globus Medical (NYSE:GMED) and Acutus Medical (NASDAQ:AFIB)March 29, 2024 | finance.yahoo.comGlobus Medical (NYSE:GMED) investors are sitting on a loss of 13% if they invested three years agoMarch 24, 2024 | investorplace.comFrom Six Figures to Seven: 3 Robotics Stocks Set to Make MillionairesApril 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.March 19, 2024 | msn.com1 'Strong Buy' Growth Stock Wall Street Expects to Soar Around 70%March 18, 2024 | theglobeandmail.comStrength in Technology Stocks Leads the Broader Market HigherMarch 18, 2024 | theglobeandmail.comStocks Rally on Strength in Technology StocksMarch 16, 2024 | nasdaq.comGlobus Medical (GMED) Shares Cross Below 200 DMAMarch 16, 2024 | finance.yahoo.comGMED Apr 2024 57.500 callMarch 16, 2024 | finance.yahoo.comGMED Apr 2024 50.000 putFebruary 27, 2024 | seekingalpha.comGlobus Medical Q4: Greater Dis-Synergies Hold Back The StockFebruary 25, 2024 | msn.comNeedham sees orthopedics market slowing; favors Enovis, Paragon 28February 22, 2024 | finance.yahoo.comGlobus Medical Full Year 2023 Earnings: EPS Misses ExpectationsFebruary 21, 2024 | realmoney.thestreet.comGlobus Medical price target raised by $3 at Stifel, here's whyFebruary 21, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Globus Medical (GMED), Universal Health (UHS) and RAPT Therapeutics (RAPT)February 21, 2024 | finance.yahoo.comGlobus Medical, Inc. (NYSE:GMED) Q4 2023 Earnings Call TranscriptFebruary 21, 2024 | finance.yahoo.comCompared to Estimates, Globus Medical (GMED) Q4 Earnings: A Look at Key MetricsFebruary 21, 2024 | fool.comGlobus Medical (GMED) Q4 2023 Earnings Call TranscriptFebruary 20, 2024 | benzinga.comGlobus Medical: Q4 Earnings InsightsFebruary 20, 2024 | seekingalpha.comGlobus Medical Non-GAAP EPS of $0.60 misses by $0.01, revenue of $616.53M beats by $8.36MFebruary 20, 2024 | markets.businessinsider.comGlobus Medical Reports Fourth Quarter and Full Year 2023 ResultsFebruary 20, 2024 | finance.yahoo.comGlobus Medical Inc (GMED) Posts Record Sales Amid NuVasive Merger, Despite Net Income DipSee More Headlines Receive GMED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Globus Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/20/2024Today4/25/2024Next Earnings (Confirmed)5/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment Current SymbolNYSE:GMED CUSIP37957720 CIK1237831 Webwww.globusmedical.com Phone(610) 930-1800Fax610-930-2042Employees5,000Year FoundedN/APrice Target and Rating Average Stock Price Target$66.33 High Stock Price Target$86.00 Low Stock Price Target$53.00 Potential Upside/Downside+30.9%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)$1.17 Trailing P/E Ratio43.30 Forward P/E Ratio18.83 P/E Growth1.51Net Income$122.87 million Net Margins7.83% Pretax Margin10.55% Return on Equity8.82% Return on Assets7.20% Debt Debt-to-Equity Ratio0.10 Current Ratio4.88 Quick Ratio2.72 Sales & Book Value Annual Sales$1.02 billion Price / Sales6.72 Cash Flow$3.57 per share Price / Cash Flow14.21 Book Value$29.32 per share Price / Book1.73Miscellaneous Outstanding Shares135,370,000Free Float102,477,000Market Cap$6.86 billion OptionableOptionable Beta1.08 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. David C. Paul (Age 57)Co-Founder & Executive Chairman Comp: $1.09MMr. Daniel T. Scavilla (Age 59)President, CEO & Director Comp: $1.37MMr. Keith W. Pfeil (Age 44)CFO & COO Comp: $675.89kMs. Kelly G. Huller Esq. (Age 52)Senior VP, General Counsel & Secretary Comp: $543.24kMr. Brian J. Kearns (Age 57)Senior Vice President of Business Development & Investor Relations Key CompetitorsTeleflexNYSE:TFXIntegra LifeSciencesNASDAQ:IARTInsuletNASDAQ:PODDAlphatecNASDAQ:ATECBaxter InternationalNYSE:BAXView All CompetitorsInsiders & InstitutionsSimplex Trading LLCBought 3,100 shares on 4/25/2024Ownership: 0.000%Amalgamated BankSold 11,180 shares on 4/23/2024Ownership: 0.047%Rice Hall James & Associates LLCBought 12,315 shares on 4/23/2024Ownership: 0.043%Louisiana State Employees Retirement SystemBought 800 shares on 4/23/2024Ownership: 0.025%Fifth Third BancorpBought 1,911 shares on 4/23/2024Ownership: 0.005%View All Insider TransactionsView All Institutional Transactions GMED Stock Analysis - Frequently Asked Questions Should I buy or sell Globus Medical stock right now? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Globus Medical in the last twelve months. There are currently 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" GMED shares. View GMED analyst ratings or view top-rated stocks. What is Globus Medical's stock price target for 2024? 9 brokerages have issued 12-month price targets for Globus Medical's stock. Their GMED share price targets range from $53.00 to $86.00. On average, they predict the company's share price to reach $66.33 in the next year. This suggests a possible upside of 30.9% from the stock's current price. View analysts price targets for GMED or view top-rated stocks among Wall Street analysts. How have GMED shares performed in 2024? Globus Medical's stock was trading at $53.29 at the beginning of the year. Since then, GMED stock has decreased by 4.9% and is now trading at $50.66. View the best growth stocks for 2024 here. Are investors shorting Globus Medical? Globus Medical saw a increase in short interest in March. As of March 31st, there was short interest totaling 7,760,000 shares, an increase of 32.4% from the March 15th total of 5,860,000 shares. Based on an average trading volume of 1,160,000 shares, the short-interest ratio is currently 6.7 days. View Globus Medical's Short Interest. When is Globus Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our GMED earnings forecast. How can I listen to Globus Medical's earnings call? Globus Medical will be holding an earnings conference call on Tuesday, May 7th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link. How were Globus Medical's earnings last quarter? Globus Medical, Inc. (NYSE:GMED) issued its earnings results on Tuesday, February, 20th. The medical device company reported $0.60 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.59 by $0.01. The medical device company had revenue of $616.53 million for the quarter, compared to analyst estimates of $608.21 million. Globus Medical had a trailing twelve-month return on equity of 8.82% and a net margin of 7.83%. The business's revenue for the quarter was up 124.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.59 earnings per share. What ETFs hold Globus Medical's stock? ETFs with the largest weight of Globus Medical (NYSE:GMED) stock in their portfolio include Motley Fool Mid-Cap Growth ETF (TMFM), MFAM Small-Cap Growth ETF (MFMS), Motley Fool Small-Cap Growth ETF (TMFS), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and SPDR S&P Health Care Equipment ETF (XHE).iShares U.S. Medical Devices ETF (IHI). What guidance has Globus Medical issued on next quarter's earnings? Globus Medical issued an update on its FY 2024 earnings guidance on Tuesday, February, 20th. The company provided earnings per share guidance of 2.680-2.700 for the period, compared to the consensus EPS estimate of 2.690. The company issued revenue guidance of $2.5 billion-$2.5 billion, compared to the consensus revenue estimate of $2.5 billion. What is David Demski's approval rating as Globus Medical's CEO? 47 employees have rated Globus Medical Chief Executive Officer David Demski on Glassdoor.com. David Demski has an approval rating of 61% among the company's employees. This puts David Demski in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Globus Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Globus Medical investors own include NVIDIA (NVDA), Shopify (SHOP), CrowdStrike (CRWD), Okta (OKTA), Trade Desk (TTD), Block (SQ), Tesla (TSLA), Teladoc Health (TDOC), Zoom Video Communications (ZM) and Mastercard (MA). Who are Globus Medical's major shareholders? Globus Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vaughan Nelson Investment Management L.P. (0.71%), Allspring Global Investments Holdings LLC (0.59%), Raymond James & Associates (0.18%), Leeward Investments LLC MA (0.16%), Bridge City Capital LLC (0.06%) and Amalgamated Bank (0.05%). Insiders that own company stock include Dan Lemaitre, Daniel T Scavilla, Daniel T Scavilla, David D Davidar, David M Demski, James R Tobin, James R Tobin, Keith W Pfeil, Keith W Pfeil, Kelly Huller and Leslie V Norwalk. View institutional ownership trends. How do I buy shares of Globus Medical? Shares of GMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:GMED) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsThe World's First "$20 Trillion Drug?"Behind the MarketsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry ResearchForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Globus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
